SCHEMBL7748824

SCHEMBL7748824

CS(=O)(=O)n1c(Cn2c3ccccc3c3ccccc32)nc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
USP2 O75604 1/20 0.44
NPSR1 Q6W5P4 4/20 0.42
MAPT P10636 3/20 0.41
AGER Q15109 1/20 0.41
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 2/20 0.40
POLB P06746 1/20 0.40
CYP19A1 P11511 1/20 0.40
LMNA P02545 3/20 0.40
PKM P14618 2/20 0.40
GAA P10253 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5859680 0.79 MEN1 (0.50) CYP1A2CYP2C19CYP3A4CYP2D6SMN1; SMN2
SCHEMBL5858877 0.79 CYP1A2 (0.48) CYP1A2CYP2C19CYP3A4CYP2D6SMN1; SMN2
SCHEMBL9039161 0.73 CYP1A2 (0.55) CYP1A2CYP2C19CYP3A4CYP2D6SMN1; SMN2
SCHEMBL7746704 0.70 TOP2A (0.55) CYP2D6USP2NPSR1MAPTALDH1A1
SCHEMBL7837246 0.70 SMN1; SMN2 (0.56) CYP1A2CYP2C19SMN1; SMN2ALDH1A1KDM4E
SCHEMBL8034260 0.70 SMN1; SMN2 (0.49) CYP1A2CYP2C19CYP3A4CYP2D6SMN1; SMN2
SCHEMBL4873241 0.70 NOD1 (0.66) CYP1A2CYP2D6SMN1; SMN2MEN1KMT2A
SCHEMBL14524222 0.70 AGTR1 (0.54) CYP1A2CYP2C19ALDH1A1KDM4EPOLB
SCHEMBL16604021 0.69 MAPT (0.63) SMN1; SMN2USP2NPSR1MAPTAGER
SCHEMBL3823423 0.68 TSHR (0.57) CYP1A2CYP2C19SMN1; SMN2USP2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed